Twist Bioscience Corp expected to post a loss of $1.13 a share - Earnings Preview

Twist Bioscience

01/02/2023 14:26

* Twist Bioscience Corp  TWST.OQ   TWST.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
3. 
    * The South San Francisco California-based  company is
expected to
report  a 28.7% increase in revenue to $54.096 million from
$42.02 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
November 18 2022, for the period ended December 31, was for
revenue of $54.000 million.
    * ​Refinitiv's mean analyst estimate for Twist Bioscience
Corp is
for a loss of $1.13 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Twist
Bioscience
Corp is $36​, above​ its last closing price of $28.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -1.25       -1.25      -0.91     Beat    27.1
 Jun. 30 2022  -1.31       -1.31      -1.08     Beat    17.5
 Mar. 31 2022  -1.28       -1.28      -1.13     Beat    11.5​
 Dec. 31 2021  -1.07       -1.06      -0.91     Beat    14.5
 ​​Sep.        -0.80       -0.79      -0.84     Missed  -5.8
 30 2021                                                
 Jun. 30 2021  -0.75       -0.75      -0.78     Missed  -3.8​
 Mar. 31 2021  -0.77       -0.77      -0.78     Missed  -1.6
 Dec. 31 2020  -0.74       -0.74      -0.72     Beat    2.4
 This summary was machine generated February 1 at 14:26 GMT.  All
figures in US dollars  unless otherwise stated